Compare Injective (INJ) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Venom — how do they compare? Injective trades at Rp74,708 (market cap Rp7,84T, Rp671,51M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Injective is far larger — about 23000.6× Venom's market cap, and Venom's supply is capped (988,9M / 8B VENOM (13%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Venom for 24 Days on average.
| INJ | VENOM | |
|---|---|---|
Market Cap | Rp7,84T | Rp340,86M |
Volume (24h) | Rp671,51M | Rp2,89M |
Circulating Supply | 100M INJ | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 37 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
VENOM displays limited market activity with a modest market cap of Rp340.86M and only 13% of its maximum 8M token supply in circulation. The asset shows minimal trading volume and network activity, with an average hold time of 24 days indicating cautious investor behavior. No recent protocol updates or significant ecosystem developments have been observed, suggesting stagnant project growth.
Overall outlook remains cautious due to limited liquidity and adoption. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor for any signs of renewed developer activity or exchange listings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
